Ann: Preliminary Final Report, page-52

Dont worry mate.
After the CEO gets Fillerina out there in Aus, the Japanese climb on board through the pharmacies, China ends up thinking that Evolis is the best thing since baked beans and thousands of high profile millenials take to the social media with raving endorsements, all accompanied by an orphan drug clinical trial for perhaps kidney disease, glioblastoma or even melanoma plus the signing of PEB and Kaiser along with the CMS, I would be suggesting a slight uplift in the SP to say 43 -44 cents at least.